Object. To evaluate a newly developed enzyme-linked immunosorbent assay (ELISA) (Hitazyme C. pneumoniae) 
Introduction

Chlamydophila pneumoniae is a major pathogen in respiratory infections (1-6). It is involved in a wide spectrum of various respiratory tract infections in both immunocompetent and immunocompromised hosts. Several studies have suggested possible association of C. pneumoniae infection and acute exacerbation of asthma and chronic obstructive pulmonary disease (COPD) (1-4). Current detection methods of C. pneumoniae include culturing, antigen detection assays (the direct fluorescent antibody assay and enzyme immunoassay), serology and molecular techniques
 (1, 7 T a b l e 1 . P r e v a l e n c e o f C. p n e u mo n i a e I g M An t i b o d y i n Di f f e r e n t Un d e r l y i n g L u n g Di s e a s e
Patients and Methods
Study population
C. pneumoniae infection appears much more common in patients with chronic lung diseases than in age-matched controls (2) (3) (4) 6 
t r i b u t i o n o f I g M a n t i b o d y t i t e r t o C h l a my d o p h i l a p n e u mo n i a e u s i n g t h e E L I S A k i t , i n 2 0 5 p a t i e n t s wi t h s t a b l e c h r o n i c l u n g d i s e a s e s ( b l a c k b a r ) a n d 1 1 6 h e a l t h y c o n t r o l s ( w h i t e b a r ) .
kyo) and C. pneumoniae species-specific monoclonal antibodies were used to stain inclusions (9) . Inclusions were observed with a Nikon epifluorescence microscope at ×200 or ×400 magnification.
Serology
The ELISA kit ( Fig. 1 i g u r e 2 . Ch a n g e o f I g M a n t i b o d y t i t e r t o C h l a my d o p h i l a p n e u mo n i a e i n 3 4 I g M-p o s i t i v e c a s e s u s i n g t h e E L I S A k i t , f o r s i x mo n t h s . 
Results
Distribution of the IgM index measured by the ELISA kit in the patients and healthy subjects is shown in
